Member Info for MoreThanMe

The 190p support held a second time and we are on the way up again today. I feel for the people waiting on sides to get in at the placing price or below, you know the company's value proposition here and the potential. Very happy with the company's strategy and happy to be a shareholder here. GLA

Similar to the breakouts on at the start of September and end of September, ODX is once again primed to breakout. This is an excellent oppertunity to top up and definitely not the time to sell. Please see chart below, showing the similarities in current price behaviour and previous breakouts.

chart: https://imgur.com/a/jXZ0Keg

@Eva I do agree that there will/could be some further down days to come, but with a placing there are always a lot of people waiting on the sidelines, hoping to pick up shares on the cheap when the share price usually drops below the placing price. But if this doesn't happen, then these people on the sidelines know the value of the company, they want in and will have to buy in at a higher price.

There was clearly huge demand for shares today, with the placing filled before the market even opened and any shares under £2 getting hooved up pretty fast. The news released with the placing was huge, outlining a clear path towards approval, increasing manufacturing capacity and starting to generate significant revenue.

Close at £2.02, considering the amount raised at £1.75 is a very strong performance today, didn't even get close to the placing price. The money raised has trasnformed the company and put it in a position of strength to negotiate with pharmas when the time comes. GLA

Why not invest in BRH? How about because the CEO of BRH dumped a good portion of his shares as the company's share price was tanking at the start of June. Why would the CEO of BRH dump so many shares at 22p?

BRH RNS link: https://www.lse.co.uk/rns/BRH/directorpdmr-shareholding-2xidwbwekwhyp1o.html

Well said Golfer boy, for every rise, a pullback is needed to let in buyers for the next leg up. We had the rise to 68p in July, followed by consolidation and pullback to 50p, then a rise to 95p in September, followed by consolidation and pullback to 65p, then another rise to 126p, followed by a pullback consolidation at 90p region. Can anyone guess where this is going next?

With the placing completed so quickly there must be some institutions that missed the boat and have no option but to buy in the open market. I am sure we will drop at some point today, but there will be strong institutional buying of anything sub £2. We are becoming a big player now.

Hourly chart looking very good now. I can see a retest of the previous high at 260p in the coming trading sessions, even without an RNS from the company. Going into winter, why would such a promising treatment with fantastic results not be fully utilised to reduce the numbers of fatalities?

I love that Merchant was away for 4 days and there are people worrying if he has sold out. For one, Merchant deserves to have as many days off this bb as he want, especially after the amazing research and contributions that he makes to this bb.

But more importantly, people should not be following investment advice from anyone on this bb. If any poster sells out of their investment here, it shouldn't have any impact on them because they should have independently researched and made their own assements of the company's value proposition. Lets not forget the saga with Dibs not so long ago.

Looking good here, bounced off the bottom of the rising trend channel and is looking ready to bounce back after being oversold over the last few days.

chart: https://imgur.com/a/KblGB1B

Very strong bounce off the 200p level retest, will lead to an exciting day here. I think the growing importance of interferons is really starting to gain traction and push SNG001 into the limelight. Very exciting, but it has felt like a long wait at times. GLA

Can anyone else confirm that a 300k trade just went through?

Volatility is to be expected after our rise yesterday and if you have held long enough here in SNG you should be used to volatility.

I have to applaud Zwartkops, he did call this and said he would buy back in at 200p after selling at 220p, but a 10% for a risk of being locked out is not something I would risk doing with Synairgen, there is a high likelyhood of breaking out of its trading range to new highs very soon.

With the strength of the price action today, I think we will rise into the close, all resistance points were smashed through today with ease, there are a lot of buyers here buying every dip very aggressively. About time too, this has been undervalued for a while now.

Stop loss is not a good idea. Our rise today is nothing to do with expections of a mention, I don't know why anyone is expecting an announcement. When an announcement comes it will be out of trading hours, or through an RNS

Look at the economic destruction unfolding infront of us and the obscene amounts of money governements are spending to prop up the economy. Tests offer a way forward for all countries that are struggling, ODX is a specialist in lateral flow tests which will be the second generation of testing that will make tests availible to the masses, unlike the slow, expensive and sparcly availible 1st generation lab tests.

Think how much money the governement can stop spending if they can use testsing to reopen the economy.

About time this started to fly, the potential on offer with SNG001 is huge and I cannot believe that the price dropped to the £1.40s, from all the research I have done SNG001 seems to be the most promising drug availible. Long covid is very real and damaging to the young and old, the ability of SNG001 to mediate the bodies immune response before the body damages itself to severely is incredible. Well done to those that have held through the difficuilt days of June/July and more recently.

Drop the price to wipe out stops and panic some of the weak hands. Seen it so many times having been invested here over 6 months, so predictable it is boring now. Do the research, ignore intraday price movements and keep your eye on the prize and you will be rewarded here.

The press is just obsessed with bashing anything that sounds anything like the botched tests brought from China earlier in the year, but when the media finally understands and fully digests how good our test is, we will start to see a change in media sentiment towards lateral flow tests. Lateral flow tests are the key for us to return back to some normality, no other type of test is as cheap, portable and accurate.

Just my opinion, but bombarding John Deek's Twitter and mass emailing The Guardian will bring more bad than good. Let the abc-19 test's performance speak for itself and don't stoop to the lowly level that The Guardian article was on. Abingdon and Omega have a reptuation to uphold and will address any media mis-representation through their own channels in a far more professional and productive way that any user of Twitter or LSE.